Back
Provident Financial Services Vs. Avidity Biosciences Industry Stock Comparison
Buy
78
PFS
Provident Financial Services
Last Price:
21.18
Seasonality Move:
0.41%
Sell
39
RNA
Avidity Biosciences
Last Price:
46.69
Seasonality Move:
33.04%
Buy
78
Provident Financial Services (PFS)
is a Buy
Is Provident Financial Services a Buy, Sell or Hold?
- The current Provident Financial Services [PFS] share price is $21.18. The Score for PFS is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- PFS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $46.71. The Score for RNA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PFS Stock Price Chart
What is Provident Financial Services's stock price today?
-
The Provident Financial Services share price today is $21.18
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PFS is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $46.71
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
PFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.56 | Buy |
| Relative Strength Index (14 RSI): | 65.91 | Buy |
| Chaikin Money Flow: | -360191 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.1 - 20.08) | Buy |
| Bollinger Bands (100): | (15.9 - 19.5) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 54.01 | Buy |
| Chaikin Money Flow: | 478392 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.93 - 47.73) | Buy |
| Bollinger Bands (100): | (41.07 - 46.53) | Buy |
PFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.79 | Buy |
| 20-day SMA: | 19.38 | Buy |
| 50-day SMA: | 18.76 | Buy |
| 200-day SMA: | 16.35 | Buy |
| 8-day EMA: | 20.18 | Buy |
| 20-day EMA: | 19.48 | Buy |
| 50-day EMA: | 18.77 | Buy |
| 200-day EMA: | 17.22 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.84 | Buy |
| 20-day SMA: | 45.91 | Buy |
| 50-day SMA: | 44.53 | Buy |
| 200-day SMA: | 33.31 | Buy |
| 8-day EMA: | 45.81 | Buy |
| 20-day EMA: | 45.52 | Buy |
| 50-day EMA: | 44.7 | Buy |
| 200-day EMA: | 34.96 | Buy |
Provident Financial Services Earnings Growth & PFS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.26 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.40 per share.
Provident Financial Services Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||